Europese Unie - Nederlands - EMA (European Medicines Agency)

blueprint medicines (netherlands) b.v. - avapritinib - gastro-intestinale stromale tumoren - andere antineoplastische middelen, proteïne kinase remmers - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.